Tirzepatide
Tirzepatide is once-weekly injectable dual glucagon-like peptide 1 (GLP-1) receptor and glucose-dependent insulinotropic polypeptide (GIP) receptor agonist. It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Tirzepatide acts in the following ways:
● Delays how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
● Slows intestinal motility so you will feel fuller longer after meals.
● Dual action receptor allows for lower blood sugars, in part by reducing the production of sugar in the liver.● Stimulates insulin secretion by the pancreas.
● GIP increases energy expenditure, resulting in weight loss reductions
Semaglutide
Semaglutide is a modified molecule our bodies make, called a GLP-1 analog. It works by increasing insulin production and lowers glucagon secretion as well as targets areas in the brain that regulate appetite and food intake. A small change in the molecule allows the drug to last weeks in our bodies rather than the natural version our bodies make, which lasts minutes.
Semaglutide acts in the following ways:
● Delays how quickly our stomachs digest food. Leading to a feeling of fullness and satisfaction with smaller meal sizes.
● Slows intestinal motility so you will feel fuller longer after meals.
● Lowers blood sugars, in part by reducing the production of sugar in the liver.
● Stimulates insulin secretion by the pancreas.
Phentermine
Peptide therapy is a medical treatment that involves the use of peptides—short chains of amino acids that are the building blocks of proteins—to regulate and improve various physiological functions in the body. Peptides act as signaling molecules, instructing cells on how to function, which makes them useful in a variety of therapeutic applications.